Antibodies
23 August 2011
Seattle Genetics Announces Initiation of a Phase II Clinical Trial of ADCETRIS in CD30-Positive Non-Hodgkin Lymphoma22 August 2011
Oncobiologics, Inc. and Fox Chase Cancer Center Announce Co-Development of a Novel Cancer Therapy Platform19 August 2011
Seattle Genetics Announces FDA Accelerated Approval of ADCETRIS (Brentuximab Vedotin) for Two Indications17 August 2011
Regeneron Announces Review of Biologics License Application for EYLEA (aflibercept injection) Extended by Three Months by FDA5 August 2011
Roche’s RoACTEMRA approved in Europe for children living with a rare and severe form of arthritis5 August 2011
Roche’s investigational treatment for asthma met its primary endpoint in a phase II study1 August 2011
Humabs discovers the first antibody to neutralize both group 1 and group 2 influenza A viruses27 July 2011
Epitomics Releases New Antibodies Developed With the National Cancer Institute’s Center for Cancer Research22 July 2011
FDA Advisory Committee Recommends Approval of REMICADE for Treatment of Pediatric Ulcerative ColitisNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports